JP2017510542A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017510542A5 JP2017510542A5 JP2016533700A JP2016533700A JP2017510542A5 JP 2017510542 A5 JP2017510542 A5 JP 2017510542A5 JP 2016533700 A JP2016533700 A JP 2016533700A JP 2016533700 A JP2016533700 A JP 2016533700A JP 2017510542 A5 JP2017510542 A5 JP 2017510542A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- gene editing
- gene
- editing protein
- synthetic rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000010362 genome editing Methods 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 102000004169 proteins and genes Human genes 0.000 claims 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 4
- 101100114361 Arabidopsis thaliana COL7 gene Proteins 0.000 claims 3
- 101710163270 Nuclease Proteins 0.000 claims 3
- 208000010975 Dystrophic epidermolysis bullosa Diseases 0.000 claims 2
- 208000004298 epidermolysis bullosa dystrophica Diseases 0.000 claims 2
- 210000002510 keratinocyte Anatomy 0.000 claims 2
- 108091033409 CRISPR Proteins 0.000 claims 1
- 238000010354 CRISPR gene editing Methods 0.000 claims 1
- 102000014914 Carrier Proteins Human genes 0.000 claims 1
- 230000004568 DNA-binding Effects 0.000 claims 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 108091036407 Polyadenylation Proteins 0.000 claims 1
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 108091008324 binding proteins Proteins 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000005782 double-strand break Effects 0.000 claims 1
- 239000012636 effector Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 230000005783 single-strand break Effects 0.000 claims 1
- 230000002103 transcriptional effect Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461934397P | 2014-01-31 | 2014-01-31 | |
| US61/934,397 | 2014-01-31 | ||
| US201462038608P | 2014-08-18 | 2014-08-18 | |
| US62/038,608 | 2014-08-18 | ||
| US201462069667P | 2014-10-28 | 2014-10-28 | |
| US62/069,667 | 2014-10-28 | ||
| PCT/US2015/013949 WO2015117021A1 (en) | 2014-01-31 | 2015-01-30 | Methods and products for nucleic acid production and delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020128881A Division JP7235702B2 (ja) | 2014-01-31 | 2020-07-30 | 核酸生成及び送達のための方法及び製品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017510542A JP2017510542A (ja) | 2017-04-13 |
| JP2017510542A5 true JP2017510542A5 (enExample) | 2018-03-08 |
Family
ID=53757787
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533700A Pending JP2017510542A (ja) | 2014-01-31 | 2015-01-30 | 核酸生成及び送達のための方法及び製品 |
| JP2020128881A Active JP7235702B2 (ja) | 2014-01-31 | 2020-07-30 | 核酸生成及び送達のための方法及び製品 |
| JP2023026873A Pending JP2023075165A (ja) | 2014-01-31 | 2023-02-24 | 核酸生成及び送達のための方法及び製品 |
| JP2024151104A Pending JP2025003953A (ja) | 2014-01-31 | 2024-09-03 | 核酸生成及び送達のための方法及び製品 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020128881A Active JP7235702B2 (ja) | 2014-01-31 | 2020-07-30 | 核酸生成及び送達のための方法及び製品 |
| JP2023026873A Pending JP2023075165A (ja) | 2014-01-31 | 2023-02-24 | 核酸生成及び送達のための方法及び製品 |
| JP2024151104A Pending JP2025003953A (ja) | 2014-01-31 | 2024-09-03 | 核酸生成及び送達のための方法及び製品 |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US9770489B2 (enExample) |
| EP (3) | EP4249036A3 (enExample) |
| JP (4) | JP2017510542A (enExample) |
| KR (3) | KR102415811B1 (enExample) |
| CN (1) | CN105940110A (enExample) |
| AU (3) | AU2015210769B2 (enExample) |
| BR (1) | BR112016017736A2 (enExample) |
| CA (1) | CA2937036A1 (enExample) |
| DK (1) | DK3690056T5 (enExample) |
| ES (2) | ES2787198T3 (enExample) |
| FI (1) | FI3690056T3 (enExample) |
| MX (2) | MX372651B (enExample) |
| RU (2) | RU2714404C2 (enExample) |
| WO (1) | WO2015117021A1 (enExample) |
Families Citing this family (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US20150044192A1 (en) | 2013-08-09 | 2015-02-12 | President And Fellows Of Harvard College | Methods for identifying a target site of a cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9737604B2 (en) | 2013-09-06 | 2017-08-22 | President And Fellows Of Harvard College | Use of cationic lipids to deliver CAS9 |
| US9340800B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | Extended DNA-sensing GRNAS |
| US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| EP4249036A3 (en) | 2014-01-31 | 2023-10-25 | Factor Bioscience Inc. | Methods and products for nucleic acid production and delivery |
| US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| WO2016070166A2 (en) | 2014-11-02 | 2016-05-06 | Arcturus Therapeutics, Inc. | Messenger una molecules and uses thereof |
| US11241505B2 (en) * | 2015-02-13 | 2022-02-08 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
| US12043852B2 (en) | 2015-10-23 | 2024-07-23 | President And Fellows Of Harvard College | Evolved Cas9 proteins for gene editing |
| EP3384038B1 (en) * | 2015-11-23 | 2024-07-24 | The Regents of The University of Colorado, A Body Corporate | Methods and compositions for reprogramming cells |
| CN109072255A (zh) | 2016-04-08 | 2018-12-21 | 克里斯托生物技术股份有限公司 | 用于治疗皮肤的伤口、病症和疾病的组合物和方法 |
| EP3241905A1 (en) * | 2016-05-06 | 2017-11-08 | Miltenyi Biotec GmbH | Method for introducing nucleic acids into a cell |
| WO2017197141A2 (en) * | 2016-05-13 | 2017-11-16 | Sangamo Therapeutics, Inc. | Targeted treatment of androgenic alopecia |
| WO2018003952A1 (ja) * | 2016-06-29 | 2018-01-04 | センジュ ユーエスエー、インコーポレイテッド | 経皮薬物送達システムおよびその使用方法 |
| CA3032699A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
| CA3033327A1 (en) | 2016-08-09 | 2018-02-15 | President And Fellows Of Harvard College | Programmable cas9-recombinase fusion proteins and uses thereof |
| IL308824A (en) * | 2016-08-17 | 2024-01-01 | Factor Bioscience Inc | Nucleic acid products and methods of administration thereof |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
| MX2019004299A (es) * | 2016-10-14 | 2019-12-05 | Neomatrix Therapeutics Inc | Peptidos derivados de fibronectina con bioactividad mejorada y sensibilidad reducida a la degradacion de la elastasa de neutrofilos. |
| US11464836B2 (en) | 2016-12-08 | 2022-10-11 | Curevac Ag | RNA for treatment or prophylaxis of a liver disease |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| JP2020510038A (ja) | 2017-03-09 | 2020-04-02 | プレジデント アンド フェローズ オブ ハーバード カレッジ | がんワクチン |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| EP3601562A1 (en) | 2017-03-23 | 2020-02-05 | President and Fellows of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| EP4019037A1 (en) | 2017-03-31 | 2022-06-29 | Accanis Biotech F&E GmbH & Co KG | Prevention and treatment of non-melanoma skin cancer (nmsc) |
| CN107400635A (zh) * | 2017-04-27 | 2017-11-28 | 广州弘宝元生物科技有限公司 | 导入α‑MSH多肽的粘红酵母重组菌株及其制备方法和应用 |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| SG11201912179SA (en) | 2017-06-15 | 2020-01-30 | Univ California | Targeted non-viral dna insertions |
| JP2020534795A (ja) | 2017-07-28 | 2020-12-03 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ファージによって支援される連続的進化（ｐａｃｅ）を用いて塩基編集因子を進化させるための方法および組成物 |
| BR102017016440A2 (pt) | 2017-07-31 | 2019-03-19 | Universidade Federal Do Rio Grande Do Sul | Composição para terapia gênica do sistema nervoso central, processo de obtenção e uso da mesma |
| EP3437650A1 (en) * | 2017-07-31 | 2019-02-06 | Accanis Biotech F&E GmbH & Co KG | Treatment of local skin hypotrophy conditions |
| US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
| CN111278447B (zh) * | 2017-09-05 | 2024-08-06 | 阿兹特拉公司 | 用重组微生物治疗炎性皮肤疾病的方法和组合物 |
| SG11202003229RA (en) * | 2017-10-11 | 2020-05-28 | Illustris Pharmaceuticals Inc | Methods and compositions for topical delivery |
| JP2021500036A (ja) | 2017-10-16 | 2021-01-07 | ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. | アデノシン塩基編集因子の使用 |
| IL305485B2 (en) | 2017-10-27 | 2025-10-01 | Univ California | Targeted replacement of endogenous T cell receptors |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| EP3543351B1 (en) | 2018-03-19 | 2022-08-10 | Ricoh Company, Ltd. | Nucleic acid sample-contained container, method for producing nucleic acid sample-contained container, and nucleic acid sample |
| CA3096081A1 (en) | 2018-04-05 | 2019-10-10 | Azitra Inc | Methods and compositions for treating skin disease with recombinant microorganisms |
| WO2019200163A1 (en) | 2018-04-12 | 2019-10-17 | Krystal Biotech, Inc. | Compositions and methods for the treatment of autosomal recessive congenital ichthyosis |
| CN119523872A (zh) * | 2018-04-27 | 2025-02-28 | 克里斯托生物技术股份有限公司 | 用于美容性应用的编码一种或多种美容蛋白的重组核酸 |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| JP7541508B2 (ja) | 2018-08-23 | 2024-08-28 | サンガモ セラピューティクス， インコーポレイテッド | 操作された標的特異的な塩基エディター |
| WO2020068862A1 (en) | 2018-09-24 | 2020-04-02 | Krystal Biotech, Inc. | Compositions and methods for the treatment of netherton syndrome |
| US20210395775A1 (en) * | 2018-09-26 | 2021-12-23 | Krystal Biotech, Inc. | Compositions and methods for the treatment of skin diseases |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| WO2020091137A1 (en) * | 2018-10-31 | 2020-05-07 | National Cancer Center | Composition comprising material for regulating oct4 modification to repress stemness |
| WO2020154500A1 (en) | 2019-01-23 | 2020-07-30 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| US10829529B2 (en) | 2019-02-08 | 2020-11-10 | Krystal Biotech, Inc. | Compositions and methods for delivering CFTR polypeptides |
| IL311628A (en) * | 2019-03-01 | 2024-05-01 | Flagship Pioneering Innovations Vi Llc | Polyribonucleotides and their cosmetic uses |
| KR20210143230A (ko) | 2019-03-19 | 2021-11-26 | 더 브로드 인스티튜트, 인코퍼레이티드 | 뉴클레오티드 서열을 편집하기 위한 방법 및 조성물 |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US20210000910A1 (en) | 2019-07-03 | 2021-01-07 | Jysk Skin Solutions Pte Ltd | Topical compositions |
| AU2020301036A1 (en) | 2019-07-03 | 2022-02-17 | Factor Bioscience Inc. | Cationic lipids and uses thereof |
| US10501404B1 (en) | 2019-07-30 | 2019-12-10 | Factor Bioscience Inc. | Cationic lipids and transfection methods |
| CN110467667B (zh) * | 2019-09-03 | 2020-11-24 | 中国科学院理化技术研究所 | 一种抗肿瘤活性肽及其应用 |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| BR112022022603A2 (pt) | 2020-05-08 | 2023-01-17 | Broad Inst Inc | Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla |
| CN114717229B (zh) * | 2021-01-05 | 2024-09-10 | 麦塞拿治疗(香港)有限公司 | 治疗性mRNA的无细胞和无载体体外RNA转录方法和核酸分子 |
| CN117412986A (zh) | 2021-04-02 | 2024-01-16 | 克里斯托生物技术股份有限公司 | 用于癌症疗法的病毒载体 |
| CN118978560A (zh) * | 2021-08-27 | 2024-11-19 | 上海兆维科技发展有限公司 | 一种加帽类似物及其应用 |
| CN118318037A (zh) * | 2021-09-08 | 2024-07-09 | 旗舰先锋创新Vi有限责任公司 | 调节基因组的方法和组合物 |
| MX2024003887A (es) | 2021-10-14 | 2024-07-09 | Arsenal Biosciences Inc | Células inmunitarias que tienen arnch coespresados y sistemas de compuerta lógica. |
| CN114150022B (zh) * | 2021-12-06 | 2023-08-22 | 中国科学院精密测量科学与技术创新研究院 | 一种基于植物微纳结构的生化分子细胞递送方法及应用 |
| JP7271026B1 (ja) | 2021-12-28 | 2023-05-11 | 株式会社Hyperion Drug Discovery | 遺伝子導入細胞の免疫応答を回避させるための剤 |
| JP2025501887A (ja) * | 2022-01-05 | 2025-01-24 | ヘリックス ナノテクノロジーズ インコーポレイテッド | アルファ因子プレプロ配列を含む組成物及びその使用 |
| CN114480365B (zh) * | 2022-01-18 | 2024-05-28 | 南昌大学 | 一种高分子-酶-无机杂化纳米花及其制备方法与其在降解食用油中真菌毒素的应用 |
| EP4501333A1 (en) * | 2022-03-30 | 2025-02-05 | Yamasa Corporation | Fibrillin production promoter, cosmetic composition or skin topical agent, orally administered agent, and elastin fiber production promoter |
| US12083204B2 (en) | 2022-06-02 | 2024-09-10 | L'oreal | Topical composition for homeostatic delivery of nitric oxide and uses thereof |
| TWI860814B (zh) | 2022-08-10 | 2024-11-01 | 南韓商韓華思路信股份有限公司 | 異氰酸酯組成物的製備方法及異氰酸酯組成物 |
| EP4656177A1 (en) * | 2023-01-27 | 2025-12-03 | Sungkwang Medical Foundation | Composition containing nidogen for improving skin condition, treating skin damage or maintaining stem cell function |
| CN116474120A (zh) * | 2023-04-03 | 2023-07-25 | 臻赫医药(杭州)有限公司 | 重编程因子抗衰老mRNA组合物、制备方法及应用 |
| WO2024214050A1 (en) * | 2023-04-11 | 2024-10-17 | Eliksa Therapeutics, Inc. | Methods of increasing therapeutic protein levels and/or improving cellular function with amniotic fluid compositions |
| WO2025024500A1 (en) * | 2023-07-25 | 2025-01-30 | Passport Technologies, Inc. | Methods and systems for transdermal immunotherapy |
| CN117683116B (zh) * | 2023-10-17 | 2025-08-15 | 百世美生物技术(浙江)有限公司 | 一种重组人源弹性蛋白及其制备方法与应用 |
| CN117904149A (zh) * | 2023-10-25 | 2024-04-19 | 中国医学科学院北京协和医院 | 一种表达酪氨酸酶的mRNA及用途 |
Family Cites Families (126)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3539465A (en) | 1968-10-08 | 1970-11-10 | Ncr Co | Encapsulation of hydrophilic liquid-in-oil emulsions |
| US5993434A (en) * | 1993-04-01 | 1999-11-30 | Genetronics, Inc. | Method of treatment using electroporation mediated delivery of drugs and genes |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US5711964A (en) | 1995-06-07 | 1998-01-27 | United States Of America | Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D |
| US6602693B1 (en) | 1996-07-03 | 2003-08-05 | Clear Solutions Biotech, Inc. | Gene encoding hyaluronan synthase |
| ATE209902T1 (de) | 1996-08-19 | 2001-12-15 | Us Gov Health & Human Serv | Neue liposomkomplexe mit erhöhter systemischer verabreichung |
| US6770291B2 (en) | 1996-08-30 | 2004-08-03 | The United States Of America As Represented By The Department Of Health And Human Services | Liposome complexes for increased systemic delivery |
| TW520297B (en) | 1996-10-11 | 2003-02-11 | Sequus Pharm Inc | Fusogenic liposome composition and method |
| WO1998030679A1 (en) | 1997-01-10 | 1998-07-16 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
| US6316260B1 (en) | 1997-08-22 | 2001-11-13 | Bernina Biosystems Gmbh | Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof |
| CA2304982A1 (en) | 1997-09-19 | 1999-03-25 | Sequitur, Inc. | Sense mrna therapy |
| US7390780B2 (en) | 1999-04-23 | 2008-06-24 | Alza Corporation | Gene delivery mediated by liposome-DNA complex with cleavable peg surface modification |
| AU5461300A (en) * | 1999-06-04 | 2000-12-28 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
| US20110171185A1 (en) | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| US20020054895A1 (en) | 1999-07-23 | 2002-05-09 | Alwyn Company, Inc. | Allantoin-containing skin cream |
| US20020064876A1 (en) * | 1999-12-28 | 2002-05-30 | Kyonggeun Yoon | Novel gene therapy methods for the treatment of skin disorders |
| US6595947B1 (en) | 2000-05-22 | 2003-07-22 | Becton, Dickinson And Company | Topical delivery of vaccines |
| ES2298269T3 (es) | 2000-09-26 | 2008-05-16 | Idera Pharmaceuticals, Inc. | Modulacion de la actividad inmunoestimulante de analogos oligonucleotidicos inmunoestimulantes mediante cambios quimicos posicionales. |
| US7189759B2 (en) | 2001-05-23 | 2007-03-13 | Medicis Pharmaceutical Corporation | Compositions for the treatment of pigmentation disorders and methods for their manufacture |
| WO2003018767A2 (en) | 2001-08-27 | 2003-03-06 | Advanced Cell Technology, Inc. | Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
| CA2461185A1 (en) | 2001-09-21 | 2003-04-03 | Japan Science And Technology Corporation | Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs |
| US20030138951A1 (en) | 2001-10-18 | 2003-07-24 | Li Yin | Conversion of liver stem and progenitor cells to pancreatic functional cells |
| US7276489B2 (en) | 2002-10-24 | 2007-10-02 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| GB0202149D0 (en) | 2002-01-30 | 2002-03-20 | Univ Edinburgh | Pluripotency determining factors and uses thereof |
| US20030186249A1 (en) * | 2002-04-01 | 2003-10-02 | Zairen Sun | Human TARPP genes and polypeptides |
| JP3785508B2 (ja) | 2002-04-15 | 2006-06-14 | 学校法人慶應義塾 | 遺伝子治療における免疫応答を解析できる実験モデルマウス |
| US7737182B2 (en) * | 2002-08-09 | 2010-06-15 | Taisho Pharmaceutical Co., Ltd. | Pharmaceuticals for xerosis |
| EP1633307A4 (en) | 2003-06-03 | 2009-06-24 | Isis Pharmaceuticals Inc | Modulation of survivin expression |
| JP2005046073A (ja) * | 2003-07-29 | 2005-02-24 | National Institute Of Advanced Industrial & Technology | 修飾核酸を用いるｒｎａ転写および／または増幅方法 |
| US7682828B2 (en) | 2003-11-26 | 2010-03-23 | Whitehead Institute For Biomedical Research | Methods for reprogramming somatic cells |
| DK3196296T3 (en) | 2004-09-08 | 2019-02-04 | Wisconsin Alumini Res Foundation | Cultivation of human embryonic stem cells |
| AU2005282510B2 (en) | 2004-09-08 | 2010-12-02 | Wisconsin Alumni Research Foundation | Medium and culture of embryonic stem cells |
| WO2007014275A2 (en) | 2005-07-26 | 2007-02-01 | Sangamo Biosciences, Inc. | Targeted integration and expression of exogenous nucleic acid sequences |
| US8323666B2 (en) | 2005-08-01 | 2012-12-04 | Allergan, Inc. | Botulinum toxin compositions |
| US9012219B2 (en) | 2005-08-23 | 2015-04-21 | The Trustees Of The University Of Pennsylvania | RNA preparations comprising purified modified RNA for reprogramming cells |
| TR201909609T4 (tr) | 2005-08-23 | 2019-07-22 | Univ Pennsylvania | Modifiye edilmiş nükleosidleri içeren rna ve kullanım yöntemleri. |
| WO2007026353A2 (en) | 2005-08-29 | 2007-03-08 | Technion Research & Development Foundation Ltd. | Media for culturing stem cells |
| US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| EA018039B1 (ru) | 2005-12-13 | 2013-05-30 | Киото Юниверсити | Ядерный фактор перепрограммирования |
| US8129187B2 (en) | 2005-12-13 | 2012-03-06 | Kyoto University | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 |
| KR20080078010A (ko) | 2005-12-22 | 2008-08-26 | 체에스엘 베링 게엠베하 | 옥타노에이트-감소된 사람 알부민 |
| DE102006051516A1 (de) | 2006-10-31 | 2008-05-08 | Curevac Gmbh | (Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins |
| GB0623635D0 (en) | 2006-11-27 | 2007-01-03 | Stem Cell Sciences Uk Ltd | Pluripotent cell growth media |
| EP2099496A2 (en) | 2006-12-08 | 2009-09-16 | Massachusetts Institute of Technology | Delivery of nanoparticles and/or agents to cells |
| CN101200758A (zh) | 2006-12-15 | 2008-06-18 | 华中科技大学 | 一种检测col7a1基因突变的方法及其用途 |
| US10829733B2 (en) | 2007-01-04 | 2020-11-10 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| US9249423B2 (en) | 2007-02-02 | 2016-02-02 | Yale University | Method of de-differentiating and re-differentiating somatic cells using RNA |
| US8859229B2 (en) | 2007-02-02 | 2014-10-14 | Yale University | Transient transfection with RNA |
| JP5813321B2 (ja) | 2007-03-23 | 2015-11-17 | ウィスコンシン アラムニ リサーチ ファンデーション | 体細胞の再プログラム化 |
| MX348010B (es) | 2007-04-07 | 2017-05-23 | Whitehead Inst Biomedical Res | Reprogramacion de celulas somaticas. |
| WO2009046739A1 (en) * | 2007-10-09 | 2009-04-16 | Curevac Gmbh | Composition for treating prostate cancer (pca) |
| KR101532442B1 (ko) | 2007-12-10 | 2015-06-29 | 고쿠리츠 다이가쿠 호진 교토 다이가쿠 | 효율적인 핵 초기화 방법 |
| EP2072618A1 (en) | 2007-12-14 | 2009-06-24 | Johannes Gutenberg-Universität Mainz | Use of RNA for reprogramming somatic cells |
| KR101679082B1 (ko) | 2008-03-17 | 2016-11-23 | 더 스크립스 리서치 인스티튜트 | 유도 만능 줄기 세포 생성을 위한 화학적 및 유전적 조합 접근법 |
| US20110045001A1 (en) | 2008-03-28 | 2011-02-24 | Biontex Laboratories Gmbh | Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| WO2009127230A1 (en) | 2008-04-16 | 2009-10-22 | Curevac Gmbh | MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION |
| ES2587395T3 (es) | 2008-06-04 | 2016-10-24 | Cellular Dynamics International, Inc. | Procedimientos para la producción de células IPS usando un enfoque no vírico |
| GB2460552B (en) | 2008-06-05 | 2011-09-07 | Iti Scotland Ltd | Stem cell culture media and methods |
| US8669048B2 (en) | 2008-06-24 | 2014-03-11 | Parkinson's Institute | Pluripotent cell lines and methods of use thereof |
| US20100184033A1 (en) | 2008-07-16 | 2010-07-22 | West Michael D | Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby |
| EP2151248A1 (en) | 2008-07-30 | 2010-02-10 | Johann Bauer | Improved pre-mRNA trans-splicing molecule (RTM) molecules and their uses |
| EP2326711A2 (en) | 2008-08-20 | 2011-06-01 | VIRxSYS Corporation | Compositions and methods for generation of pluripotent stem cells |
| CN102239249A (zh) | 2008-10-24 | 2011-11-09 | 威斯康星校友研究基金会 | 通过非病毒重编程获得的多潜能干细胞 |
| EP2192174B1 (en) | 2008-11-21 | 2015-11-11 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Reprogramming cells toward a pluripotent state |
| EP2206723A1 (en) | 2009-01-12 | 2010-07-14 | Bonas, Ulla | Modular DNA-binding domains |
| US20110239315A1 (en) | 2009-01-12 | 2011-09-29 | Ulla Bonas | Modular dna-binding domains and methods of use |
| US20100209404A1 (en) | 2009-02-10 | 2010-08-19 | University Of Dayton | Enhanced method for producing stem-like cells from somatic cells |
| US10894944B2 (en) | 2009-04-10 | 2021-01-19 | Monash University | Cell culture media |
| CA2759181A1 (en) * | 2009-04-22 | 2010-10-28 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long rna molecules |
| US10837020B2 (en) | 2009-04-22 | 2020-11-17 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long RNA molecules |
| ES2849181T3 (es) | 2009-04-22 | 2021-08-16 | Viacyte Inc | Composiciones celulares derivadas de células reprogramadas desdiferenciadas |
| WO2010123501A1 (en) | 2009-04-22 | 2010-10-28 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long rna molecules |
| EP2251437B1 (en) | 2009-05-13 | 2013-12-04 | Hannelore Breitenbach-Koller | Method for identifying compounds that control the translational activity of ribosomal proteins in differential mRNA expression |
| US8496941B2 (en) | 2009-06-03 | 2013-07-30 | National Institute Of Advanced Industrial Science And Technology | Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same |
| CN102695797B (zh) * | 2009-06-16 | 2018-05-25 | 库尔纳公司 | 通过抑制针对胶原基因的天然反义转录物来治疗胶原基因相关的疾病 |
| BR112012002291A2 (pt) | 2009-07-31 | 2016-11-29 | Ethris Gmbh | "polirribonucleotídeo com uma sequência que codifica uma proteína ou fragmento de proteína, implante, e, processo para a seleção de sequências de nucleotídeos" |
| JP5898086B2 (ja) | 2009-11-04 | 2016-04-06 | セルラー ダイナミクス インターナショナル， インコーポレイテッド | 化学物質を用いるエピソームリプログラミング |
| US20110189137A1 (en) | 2009-11-11 | 2011-08-04 | Sanford-Burnham Medical Research Institute | Method for generation and regulation of ips cells and compositions thereof |
| CN107090436B (zh) | 2009-12-07 | 2021-11-30 | 宾夕法尼亚州大学信托人 | 用于重编程细胞的包含纯化的经修饰的rna的rna制剂 |
| US20130189741A1 (en) | 2009-12-07 | 2013-07-25 | Cellscript, Inc. | Compositions and methods for reprogramming mammalian cells |
| AU2010327998B2 (en) | 2009-12-10 | 2015-11-12 | Iowa State University Research Foundation, Inc. | TAL effector-mediated DNA modification |
| US8557972B2 (en) | 2009-12-21 | 2013-10-15 | University Of Washington Through Its Center For Commercialization | Compositions and methods for transfection of RNA and controlled stabilization of transfected RNA |
| CA2788635A1 (en) | 2010-02-01 | 2011-08-04 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced efficiency of induced pluripotent stem cell generation |
| US20140194482A1 (en) | 2010-02-02 | 2014-07-10 | Scioderm, Inc. | Compositions and methods of treatment of inflammatory skin conditions using allantoin |
| WO2011110886A1 (en) | 2010-03-09 | 2011-09-15 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| US8802438B2 (en) | 2010-04-16 | 2014-08-12 | Children's Medical Center Corporation | Compositions, kits, and methods for making induced pluripotent stem cells using synthetic modified RNAs |
| US9725695B2 (en) | 2010-05-05 | 2017-08-08 | The Regents Of The University Of California | Stem cell defined media for xeno-free and feeder free conditions and uses thereof |
| US8048675B1 (en) | 2010-05-12 | 2011-11-01 | Ipierian, Inc. | Integration-free human induced pluripotent stem cells from blood |
| CA2799095A1 (en) | 2010-05-12 | 2011-11-17 | Cellectis | Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof |
| EP2571512B1 (en) | 2010-05-17 | 2017-08-23 | Sangamo BioSciences, Inc. | Novel dna-binding proteins and uses thereof |
| EP2392208B1 (en) | 2010-06-07 | 2016-05-04 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| AU2011285531B2 (en) | 2010-08-05 | 2015-04-30 | Wisconsin Alumni Research Foundation | Simplified basic media for human pluripotent cell culture |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2616540A4 (en) | 2010-09-14 | 2014-02-19 | Univ Kyoto | METHOD FOR EFFICIENT MANUFACTURE OF INDUCED PLURIPOTENTER STEM CELLS |
| PL3590949T3 (pl) | 2010-10-01 | 2022-08-29 | Modernatx, Inc. | Kwasy rybonukleinowe zawierające n1-metylo-pseudouracyle i ich zastosowania |
| EP2625278A1 (en) | 2010-10-08 | 2013-08-14 | Regents of the University of Minnesota | A method to increase gene targeting frequency |
| WO2012060473A1 (en) | 2010-11-04 | 2012-05-10 | Kyoto University | Method of efficiently establishing induced pluripotent stem cells |
| AU2012225497A1 (en) | 2011-03-07 | 2013-10-24 | Massachusetts Institute Of Technology | Methods for transfecting cells with nucleic acids |
| WO2012131090A1 (en) * | 2011-03-31 | 2012-10-04 | Galderma Research & Development | Method for treatment of xeroderma pigmentosum |
| DE12722942T1 (de) | 2011-03-31 | 2021-09-30 | Modernatx, Inc. | Freisetzung und formulierung von manipulierten nukleinsäuren |
| EP2694660B1 (en) | 2011-04-03 | 2018-08-08 | The General Hospital Corporation | Efficient protein expression in vivo using modified rna (mod-rna) |
| WO2012174224A2 (en) | 2011-06-17 | 2012-12-20 | Calando Pharmaceuticals, Inc. | Methods for administering nucleic acid-based therapeutics |
| WO2012176015A1 (en) * | 2011-06-24 | 2012-12-27 | Leo Pharma A/S | Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate |
| WO2013003475A1 (en) | 2011-06-27 | 2013-01-03 | Cellscript, Inc. | Inhibition of innate immune response |
| US20130040302A1 (en) | 2011-07-11 | 2013-02-14 | Thomas J. Burke | Methods for cell reprogramming and genome engineering |
| EP2753704A4 (en) | 2011-08-03 | 2015-07-08 | Lotus Tissue Repair Inc | COLLAGEN 7 AND ASSOCIATED METHODS |
| RS62993B1 (sr) | 2011-10-03 | 2022-03-31 | Modernatx Inc | Modifikovani nukleozidi, nukleotidi, i nukleinske kiseline, i njihove upotrebe |
| EP2766480B1 (en) | 2011-10-11 | 2018-03-14 | INSERM - Institut National de la Santé et de la Recherche Médicale | Exon skipping therapy for dystrophic epidermolysis bullosa |
| JP2013086009A (ja) | 2011-10-17 | 2013-05-13 | Yamamoto Co Ltd | 自動精米装置 |
| KR20250035015A (ko) * | 2011-12-05 | 2025-03-11 | 팩터 바이오사이언스 인크. | 세포를 형질감염시키는 방법들 및 생성물들 |
| US8497124B2 (en) | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
| PT2791160T (pt) | 2011-12-16 | 2022-07-04 | Modernatx Inc | Composições arnm modificado |
| CA2859691A1 (en) | 2011-12-21 | 2013-06-27 | Moderna Therapeutics, Inc. | Methods of increasing the viability or longevity of an organ or organ explant |
| LT3421601T (lt) | 2011-12-30 | 2020-01-10 | Cellscript, Llc | In vitro susintetintos ssrnr gamyba ir panaudojimas įvedimui į žinduolių ląsteles biologinio arba biocheminio poveikio sukėlimui |
| AU2013243955B2 (en) | 2012-04-02 | 2018-02-22 | Modernatx, Inc. | Modified polynucleotides for the production of oncology-related proteins and peptides |
| SG10201809901SA (en) | 2012-04-24 | 2018-12-28 | Vcell Therapeutics Inc | Generating Pluripotent Cells De Novo |
| US10155929B2 (en) | 2012-05-13 | 2018-12-18 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| US10119150B2 (en) | 2012-05-13 | 2018-11-06 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| KR102081811B1 (ko) | 2012-05-13 | 2020-02-26 | 알렐 바이오테크놀로지 앤 파마슈티칼스, 인크. | 합성 메신저 rna에 의한 인간 유도 만능 줄기 세포의 피더프리 유래 |
| US20140031295A1 (en) | 2012-07-19 | 2014-01-30 | Lotus Tissue Repair, Inc. | Recombinant C7 and Methods of Use |
| KR101979746B1 (ko) * | 2012-09-13 | 2019-05-17 | (주)아모레퍼시픽 | 전기 천공 장치 |
| SG11201504523UA (en) * | 2012-12-12 | 2015-07-30 | Broad Inst Inc | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
| CN105164269A (zh) | 2013-02-22 | 2015-12-16 | 里兰斯坦福初级大学理事会 | 与端粒延伸相关的化合物、组合物、方法和试剂盒 |
| JP6480874B2 (ja) * | 2013-03-01 | 2019-03-13 | リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタＲｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍｉｎｎｅｓｏｔａ | Ｔａｌｅｎに基づく遺伝子修正 |
| SG11201601939VA (en) * | 2013-09-16 | 2016-04-28 | Agency Science Tech & Res | Method |
| EP4249036A3 (en) | 2014-01-31 | 2023-10-25 | Factor Bioscience Inc. | Methods and products for nucleic acid production and delivery |
-
2015
- 2015-01-30 EP EP22216417.0A patent/EP4249036A3/en not_active Withdrawn
- 2015-01-30 EP EP15743915.9A patent/EP3099801B1/en active Active
- 2015-01-30 ES ES15743915T patent/ES2787198T3/es active Active
- 2015-01-30 BR BR112016017736A patent/BR112016017736A2/pt not_active Application Discontinuation
- 2015-01-30 EP EP20161924.4A patent/EP3690056B1/en active Active
- 2015-01-30 ES ES20161924T patent/ES2939542T3/es active Active
- 2015-01-30 MX MX2016009771A patent/MX372651B/es active IP Right Grant
- 2015-01-30 KR KR1020167019564A patent/KR102415811B1/ko active Active
- 2015-01-30 CN CN201580006437.9A patent/CN105940110A/zh active Pending
- 2015-01-30 AU AU2015210769A patent/AU2015210769B2/en active Active
- 2015-01-30 KR KR1020247036521A patent/KR20240162163A/ko active Pending
- 2015-01-30 CA CA2937036A patent/CA2937036A1/en active Pending
- 2015-01-30 US US14/761,461 patent/US9770489B2/en active Active
- 2015-01-30 DK DK20161924.4T patent/DK3690056T5/da active
- 2015-01-30 FI FIEP20161924.4T patent/FI3690056T3/fi active
- 2015-01-30 KR KR1020227022074A patent/KR102726294B1/ko active Active
- 2015-01-30 JP JP2016533700A patent/JP2017510542A/ja active Pending
- 2015-01-30 RU RU2016131251A patent/RU2714404C2/ru active
- 2015-01-30 RU RU2020104969A patent/RU2020104969A/ru unknown
- 2015-01-30 WO PCT/US2015/013949 patent/WO2015117021A1/en not_active Ceased
-
2016
- 2016-07-27 MX MX2020006065A patent/MX2020006065A/es unknown
-
2017
- 2017-08-16 US US15/678,491 patent/US10124042B2/en active Active
-
2018
- 2018-06-12 US US16/006,461 patent/US20180271951A1/en not_active Abandoned
-
2019
- 2019-03-07 AU AU2019201576A patent/AU2019201576A1/en not_active Abandoned
- 2019-09-06 US US16/562,494 patent/US12201675B2/en active Active
-
2020
- 2020-07-30 JP JP2020128881A patent/JP7235702B2/ja active Active
-
2022
- 2022-02-17 AU AU2022201056A patent/AU2022201056A1/en not_active Abandoned
-
2023
- 2023-02-24 JP JP2023026873A patent/JP2023075165A/ja active Pending
-
2024
- 2024-09-03 JP JP2024151104A patent/JP2025003953A/ja active Pending
- 2024-12-13 US US18/980,218 patent/US20250195622A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017510542A5 (enExample) | ||
| FI3690056T3 (fi) | Menetelmiä ja tuotteita nukleiinihapon valmistamiseksi ja viemiseksi | |
| ES2962434T3 (es) | Procedimientos y composiciones para editar ARN | |
| JP7698828B2 (ja) | Ｒｎａを編集する方法および組成物 | |
| JP7093728B2 (ja) | 化学的に修飾されたガイドｒｎａを使用する高特異性ゲノム編集 | |
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| Lim et al. | Gene silencing H-NS paralogue StpA forms a rigid protein filament along DNA that blocks DNA accessibility | |
| JP2023075165A5 (enExample) | ||
| FI3604532T3 (fi) | Uusia crispr-entsyymejä ja järjestelmiä | |
| JP6808617B2 (ja) | 連続性を維持した転位 | |
| CN109072235B (zh) | 通过核递送crispr/cas9追踪并操纵细胞rna | |
| JP2021121205A5 (enExample) | ||
| KR20160050068A (ko) | 스위칭가능한 ｃａｓ９ 뉴클레아제 및 그의 용도 | |
| JP2016512691A5 (enExample) | ||
| CN107794272A (zh) | 一种高特异性的crispr基因组编辑体系 | |
| RU2018101710A (ru) | Мутации фермента crispr, уменьшающие нецелевые эффекты | |
| JP2013530689A5 (enExample) | ||
| JP2015534817A5 (enExample) | ||
| US20190085315A1 (en) | Methods for enhancing the efficiency of gene editing | |
| Karvelis et al. | Harnessing the natural diversity and in vitro evolution of Cas9 to expand the genome editing toolbox | |
| JP2018530530A5 (enExample) | ||
| JP2013507934A5 (enExample) | ||
| WO2019117714A8 (en) | Methods for preparing nucleic acid molecules for sequencing | |
| CN114729359A (zh) | 程序性dna驱动的自组装rna水凝胶 | |
| US11939574B2 (en) | Ribosomal RNA origami and methods preparing thereof |